State of Mexico Purchases Medical Marijuana, Inc.'s Cannabis Product for Its Citizens

adminNews0 Comments

<![CDATA[SAN DIEGO, Aug. 21, 2017 — Medical Marijuana, Inc. (MJNA), the first publicly traded cannabis company in the United States, today announced that the State of Mexico’s government has purchased the company’s Real Scientific Hemp Oil-X™ (RSHO-X™) CBD hemp oil products from its subsidiary HempMeds Mexico® to treat 11 of its citizens suffering from varying indications including Refractory Epilepsy and Lennox Gastaut-Syndrome. This is the first time a government in Mexico has purchased CBD products for its citizens, according to a press release.

The State of Mexico’s Governor Eruviel Avila distributed HempMeds Mexico’s flagship product RSHO-X™, a CBD hemp oil with zero THC, to the patients at the inauguration of a new clinic located in Ecatepec on August 17th.

“We want to congratulate the State of Mexico’s government for this historic purchase of our RSHO CBD products to help improve the lives of its citizens,” said Medical Marijuana, Inc. Dr. Stuart Titus. “We are a Company of firsts, including having the first and only federally legal CBD product in Mexico and we are excited about this new historic milestone of being the first Company that the Government of Mexico has contracted to purchase and pay for cannabinoid CBD products to benefit its citizens.”

“The plethora of benefits of cannabinoids (botanical as well as pharmaceutically developed) in treating multiple indications is now being researched and we are encouraged to see significant anecdotal evidence leading the way,” added Dr. Titus. “Now, health care professionals and government health care agencies are becoming increasingly interested in how CBD hemp oil can help benefit many medical conditions, especially those conditions where conventional medicine has had modest effects.”

Dr. Saul Garza Morales, pediatric researcher and neurologist in Mexico, recently shared the positive results of a recent study he conducted on the effects of Medical Marijuana, RSHO-X™ product in treating children with severe epilepsy, in which 86 percent of the 29 patients he studied experienced statistically significant (greater than 50%) reduction in motor seizures. Seventeen percent of the children were fully seizure free for a 4-month period.

HempMeds® Mexico is the first company to receive government import permits for a cannabis product via approval by the Mexican Health Department, COFEPRIS. With these achievements and other firsts in Latin American countries like Brazil where HempMeds Brasil™ became the first company to offer legal medicinal cannabis products to Brazil after receiving import approval and Paraguay where RSHO™ was the first medical cannabis product approved for import into the country. Medical Marijuana Inc. and the company’s subsidiaries have become a leader in the Latin America cannabis industry by providing products to help those suffering from various conditions including:

-Amyotrophic Lateral Sclerosis
Source: Cannabis Business Times

Leave a Reply

Your email address will not be published. Required fields are marked *